Lorraine Fay

Lorraine Fay serves as the Executive Director and Head of Clinical Development and Quality Operations at Bristol Myers Squibb since February 2021. Prior to this role, Lorraine held several significant positions at Genentech, including Global Head of Molecule Strategy and Team Lead for GCP Strategy. Additional experience includes serving as Quality Manager at Vertex Pharmaceuticals, Clinical Quality Assurance Professional at Pfizer, and Scientist at PGRD. Lorraine's academic background includes a Master of Science in Regulatory Affairs/Quality Assurance from Temple University, a Master of Arts in Science (Organic Chemistry) from Wayne State University, and a Bachelor of Arts (mod) in Science (Chemistry) from Trinity College Dublin.